Bioactive compositions from theacea plants and use thereof in beverages, functional foods, nutriceuticals, supplements and the like

Patent metadata

Field	Value
Publication number	US-10632166-B2
Application number	US-201414766497-A
Country	US
Kind code	B2
Filing date	Feb 10, 2014
Priority date	Feb 8, 2013
Publication date	Apr 28, 2020
Grant date	Apr 28, 2020

Abstract

The present invention relates to isolated bioactive compositions containing bioactive fractions derived from Theacea plants. The present invention also relates to bioactive topical formulations containing the bioactive compositions. The present invention further relates to methods of using the bioactive compositions of the present invention, including, for example, methods for inhibiting inflammatory activity in skin tissue of a mammal, for protecting skin tissue of a mammal from ultraviolet light-induced damage, and for normalizing skin disorders in skin tissue of a mammal. The present invention also relates to methods for isolating bioactive fractions derived from cell juice or a cell walls component a Theacea plant. The bioactive compositions are suitable for use in, inter alia, beverages, functional foods, nutriceuticals, supplements, and the like.

First claim

What is claimed is:

1. A beverage comprising at least one bioactive composition dispersed in a liquid, %
wherein said liquid is selected from the group consisting of water, shot drink, functional drink, green tea, oolong tea, black tea, white tea, flavored tea, soft drink, coffee, milk, shake, alcoholic drink, non-alcoholic drink, sports drink, fruit juice, vegetable juice, artificially sweetened juice, sparkling water, punch, cider and nutritional supplement drink;
wherein said bioactive composition comprising a bioactive fraction derived from a Theacea plant;
wherein said bioactive fraction derived from a Theaceae plant is selected from the group consisting of a membrane fraction, a membrane fraction extract, a cytoplasm fraction, a cytoplasm fraction extract, a cell juice serum, and combinations thereof, for use as an antioxidant
wherein Oxygen Radical Absorbance Capacity (ORAC) value of said bioactive composition is over twenty times higher than a green tea beverage that does not contain said bioactive composition; and,
wherein said bioactive fraction comprises at least 1150 μg/ml of L-Theanine.

2. The beverage according to claim 1 , wherein said Theaceae plant is a Camellia plant or a Eurya plant.

3. The beverage according to claim 2 , wherein said Camellia plant is selected from the group consisting of Camellia sinensis, Camellia japonica, Camellia reticulate , and Camellia sasanqua , and wherein said Eurya plant is Eurya sandwicensis.

4. The beverage according to claim 1 , wherein said bioactive fraction is a membrane fraction.

5. The beverage according to claim 1 , wherein said bioactive fraction is membrane fraction extract.

6. The beverage according to claim 5 , wherein said membrane fraction extract has a total catechin content of between about 15.0 and about 30.5 milligrams per gram of dry matter.

7. The beverage according to claim 5 , wherein said membrane fraction extract has a catechin content profile comprising:
between about 1.7 and about 3.3 milligrams of (−)-epigallocatechin per gram of dry matter of the membrane fraction extract,
between about 6.1 and about 10.2 milligrams of (+)-catechin per gram of dry matter of the membrane fraction extract,
between about 0.3 and about 1.1 milligrams of (−)-epicatechin per gram of dry matter of the membrane fraction extract,
between about 6.2 and about 12.5 milligrams of (−)-epigallocatechin gallate per gram of dry matter of the membrane fraction extract,
between about 0.007 and about 0.03 milligrams of (−)-gallocatechin gallate per gram of dry matter of the membrane, and
between about 1.3 and about 3.3 milligrams of (−)-epicatechin gallate per gram of dry matter of the membrane fraction extract.

8. The beverage composition according to claim 1 , wherein said bioactive fraction is a cytoplasm fraction.

9. The beverage composition according to claim 1 , wherein said bioactive fraction is a cytoplasm fraction extract.

10. The beverage according to claim 1 , wherein said bioactive fraction is a cell juice serum.

11. The beverage according to claim 10 , wherein said cell juice serum has a total catechin content of between about 8.0 and about 20.0 milligrams per gram of dry matter.

12. The beverage according to claim 10 , wherein said cell juice serum has a catechin content profile comprising:
between about 2.1 and about 4.4 milligrams of (−)-epigallocatechin per gram of dry matter of the cell juice serum,
between about 4.2 and about 8.6 milligrams of (+)-catechin per gram of dry matter of the cell juice serum,
between about 0.2 and about 2.0 milligrams of (−)-epicatechin per gram of dry matter of the cell juice serum,
between about 1.2 and about 3.2 milligrams of (−)-epigallocatechin gallate per gram of dry matter of the cell juice serum,
between about 0.01 and about 0.1 milligrams of (−)-gallocatechin gallate per gram of dry matter of the cell juice serum, and
between about 0.2 and about 1.3 milligrams of (−)-epicatechin gallate per gram of dry matter of the cell juice serum.

13. The beverage according to claim 1 further comprising a stabilizing agent.

14. The beverage according to claim 13 , wherein said stabilizing agent is selected from the group consisting of an emulsifier, a preservative, an antioxidant, a polymer matrix, and mixtures thereof.

15. A nutriceutical product for use by a human subject as an antioxidant comprising at least one bioactive composition derived from Theaceae plant, said bioactive composition comprising an isolated bioactive fraction derived from a Theaceae plant selected from the group consisting of a membrane fraction, a membrane fraction extract, a cytoplasm fraction, a cytoplasm fraction extract, a cell juice serum, and combinations thereof,
wherein said Theacea plant is a Camellia plant selected from the group consisting of Camellia sinensis, Camellia japonica, Camellia reticulate , and Camellia sasanqua ; or a Eurya plant, which is Eurya sandwicensis ; and,
wherein said bioactive fraction comprises at least 1150 μg/ml of L-Theanine, and,
wherein said bioactive fraction has antioxidant activity when administered to the human subject orally as the nutriceutical product, and,
wherein Oxygen Radical Absorbance Capacity (ORAC) value of said bioactive composition is over twenty times higher than a second nutriceutical product that does not contain said bioactive composition.

16. The nutriceutical product according to claim 15 , wherein said Theaceae plant is a Camellia plant or a Eurya plant.

17. The nutriceutical product according to claim 16 , wherein said Camellia plant is selected from the group consisting of Camellia sinensis, Camellia japonica, Camellia reticulate , and Camellia sasanqua , and wherein said Eurya plant is Eurya sandwicensis.

18. The nutriceutical product according to claim 15 , wherein said membrane fraction extract has a total catechin content of between about 15.0 and about 30.5 milligrams per gram of dry matter.

19. The nutriceutical product according to claim 15 , wherein said membrane fraction extract has a catechin content profile comprising:
between about 1.7 and about 3.3 milligrams of (−)-epigallocatechin per gram of dry matter of the membrane fraction extract,
between about 6.1 and about 10.2 milligrams of (+)-catechin per gram of dry matter of the membrane fraction extract,
between about 0.3 and about 1.1 milligrams of (−)-epicatechin per gram of dry matter of the membrane fraction extract,
between about 6.2 and about 12.5 milligrams of (−)-epigallocatechin gallate per gram of dry matter of the membrane fraction extract,
between about 0.007 and about 0.03 milligrams of (−)-gallocatechin gallate per gram of dry matter of the membrane fraction extract, and
between about 1.3 and about 3.3 milligrams of (−)-epicatechin gallate per gram of dry matter of the membrane fraction extract.

20. The nutriceutical product according to claim 15 , wherein said bioactive fraction is a cytoplasm fraction.

21. The nutriceutical product according to claim 15 , wherein said bioactive fraction is a cytoplasm fraction extract.

22. The nutriceutical product according to claim 15 , wherein said bioactive fraction is a cell juice serum.

23. The nutriceutical product according to claim 22 , wherein said cell juice serum has a total catechin content of between about 8.0 and about 20.0 milligrams per gram of dry matter.

24. The nutriceutical product according to claim 22 , wherein sai

Assignees

• Isp Investments Inc
• Isp Investments Llc

Inventors

• Koganov Michael
• Dueva-Koganov Olga
• Duev Artyom
• Hou Xiaowen

Classifications

• B65D85/808

  for immersion in the liquid {to release part or all of their contents}, e.g. tea bags · CPC title

• A61K2236/00

  Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine · CPC title

• A61K8/498

  having 6-membered rings or their condensed derivatives, e.g. coumarin · CPC title

• A61K36/82 Primary

  Theaceae (Tea family), e.g. camellia · CPC title

• A23L2/52

  Adding ingredients (adding preservatives A23B70/10) · CPC title